We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
2326
DELISTED
CyberArk
CYBR
| $255K | ﹤0.01% |
+1,623
| New | +$246K |
|
2327
PENN Entertainment
PENN
$2.53B
| $255K | ﹤0.01% |
6,969
-12,021
| -63% | -$549K |
|
2328
Ocugen
OCGN
$444M
| $253K | ﹤0.01% |
115,351
+26,812
| +30% | +$94.2K |
|
|
OPI
2329
DELISTED
Office Properties Income Trust
OPI
| $253K | ﹤0.01% |
+11,702
| New | +$298K |
|
2330
Hovnanian Enterprises
HOV
$772M
| $250K | ﹤0.01% |
5,438
-1,212
| -18% | -$110K |
|
2331
Dream Finders Homes
DFH
$1.25B
| $249K | ﹤0.01% |
+14,376
| New | +$276K |
|
|
GTY
2332
Getty Realty Corp
GTY
$2.01B
| $249K | ﹤0.01% |
+9,240
| New | +$267K |
|
2333
Janus International
JBI
$732M
| $249K | ﹤0.01% |
+26,374
| New | +$268K |
|
2334
N-able
NABL
$605M
| $249K | ﹤0.01% |
+24,900
| New | +$262K |
|
2335
Zillow
ZG
$7.66B
| $249K | ﹤0.01% |
6,441
-21,131
| -77% | -$1.12M |
|
|
OCDX
2336
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $248K | ﹤0.01% |
14,072
-746
| -5% | -$13.4K |
|
2337
ADT
ADT
$5.49B
| $245K | ﹤0.01% |
35,703
+13,388
| +60% | +$102K |
|
|
AGTI
2338
DELISTED
Agiliti Inc
AGTI
| $243K | ﹤0.01% |
+12,313
| New | +$233K |
|
|
CCXI
2339
DELISTED
ChemoCentryx, Inc.
CCXI
| $242K | ﹤0.01% |
13,096
+6,372
| +95% | +$179K |
|
2340
Anavex Life Sciences
AVXL
$314M
| $240K | ﹤0.01% |
27,997
+5,404
| +24% | +$66.5K |
|
2341
Sixth Street Specialty
TSLX
$1.79B
| $240K | ﹤0.01% |
10,751
+861
| +9% | +$20.2K |
|
|
WW
2342
DELISTED
WW International
WW
| $240K | ﹤0.01% |
24,476
+13,027
| +114% | +$153K |
|
|
MNTV
2343
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $239K | ﹤0.01% |
15,115
-51
| -0.3% | -$852 |
|
|
AMWD
2344
DELISTED
American Woodmark
AMWD
| $238K | ﹤0.01% |
5,087
-60,366
| -92% | -$3.47M |
|
2345
CRISPR Therapeutics
CRSP
$5.17B
| $238K | ﹤0.01% |
4,792
| – | – |
|
2346
Oceaneering
OII
$5.09B
| $238K | ﹤0.01% |
20,991
+9,666
| +85% | +$139K |
|
2347
Fossil Group
FOSL
$317M
| $237K | ﹤0.01% |
+23,945
| New | +$272K |
|
|
FOLD
2348
DELISTED
Amicus Therapeutics
FOLD
| $236K | ﹤0.01% |
33,268
-780
| -2% | -$7.31K |
|
|
PAMT
2349
PAMT Corp
PAMT
$287M
| $236K | ﹤0.01% |
+7,756
| New | +$275K |
|
|
PGRE
2350
DELISTED
Paramount Group
PGRE
| $233K | ﹤0.01% |
24,482
-680
| -3% | -$6.63K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.